\u6d4b\u8bd5\u88f8\u76d6\u83c7\u7d20(\u795e\u5947\u8611\u83c7\u4e2d\u7684\u6709\u6548\u6210\u5206)<\/a>\u5bf9\u9000\u4f0d\u519b\u4eba\u548c\u9996\u6279\u53cd\u5e94\u8005\u7684\u6cbb\u7597\u987d\u6297\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u7684\u7597\u6548\u3002<\/p>\nCreso\u516c\u53f8\u5c06\u975e\u9000\u4f0d\u519b\u4eba\u7eb3\u5165\u8c03\u67e5\u5bf9\u8c61\u4e4b\u524d\uff0cHalucenex\u6536\u5230\u4e86\u5927\u91cf\u6765\u81ea\u666e\u901a\u516c\u4f17\u7684\u54a8\u8be2\uff0c\u8fd9\u4e9b\u4eba\u4e5f\u60a3\u6709\u7cbe\u795e\u75be\u75c5\uff0c\u6b63\u5728\u5bfb\u6c42\u66ff\u4ee3\u7597\u6cd5\u3002<\/p>\n
\u8be5\u516c\u53f8\u9884\u8ba1\uff0c\u975e\u9000\u4f0d\u519b\u4eba\u7684\u52a0\u5165\u5c06\u4f7f\u5176\u80fd\u591f\u6574\u7406\u989d\u5916\u7684\u6570\u636e\u96c6\uff0c\u4e3a\u88f8\u76d6\u83c7\u7d20\u4f5c\u4e3a\u66ff\u4ee3\u6cbb\u7597\u9014\u5f84\u65f6\u7684\u7597\u6548\u63d0\u4f9b\u771f\u5b9e\u7684\u4f8b\u5b50\u3002<\/p>\n
\u8be5\u8bd5\u9a8c\u7684\u6570\u636e\u5c06\u7528\u4e8e\u63a8\u8fdb\u4e0e\u6f5c\u5728\u5408\u4f5c\u4f19\u4f34\u7684\u8ba8\u8bba\uff0c\u5305\u62ec\u836f\u7269\u5f00\u53d1\u5546\u3001\u5927\u578b\u5236\u836f\u516c\u53f8\u3001\u4fdd\u9669\u4f9b\u5e94\u5546\u548c\u76d1\u7ba1\u673a\u6784\uff0c\u4ee5\u8fdb\u4e00\u6b65\u5de9\u56faHalucenex\u4f5c\u4e3a\u65b0\u5174\u81f4\u5e7b\u5242\u836f\u7269\u9886\u57df\u7684\u5148\u884c\u8005\u7684\u5730\u4f4d\u3002<\/p>\n
\u6ca1\u6709\u5f53\u8fc7\u5175\u7684\u597d\u5904<\/h2>\n
Halucenex\u9996\u5e2d\u6267\u884c\u5b98Bill Fleming\u8868\u793a\uff0c\u975e\u7ecf\u9a8c\u4e30\u5bcc\u7684\u53c2\u4e0e\u8005\u5c06\u4e3a\u8bd5\u9a8c\u5e26\u6765\u8bf8\u591a\u597d\u5904\u3002<\/p>\n
\u4ed6\u8bf4:\u201c\u968f\u7740\u7f8e\u56fd\u7684\u5404\u79cd\u76d1\u7ba1\u53d8\u5316\u4ee5\u53caCOVID-19\u5bf9\u4eba\u7fa4\u5fc3\u7406\u5065\u5eb7\u72b6\u51b5\u7684\u5f71\u54cd\u4e0d\u65ad\u6076\u5316\uff0c\u8d8a\u6765\u8d8a\u660e\u663e\u7684\u662f\uff0c\u8ff7\u5e7b\u7597\u6cd5\u53ef\u80fd\u5728\u4e0d\u4e45\u7684\u5c06\u6765\u6210\u4e3a\u4e3b\u6d41\u3002\u201d<\/p>\n
\u201c\u8ba9\u6bcf\u5929\u7684\u4eba\u53c2\u4e0e\u6211\u4eec\u7684\u7814\u7a76\u548c\u5f00\u53d1\uff0c\u5c06\u4e3a\u6211\u4eec\u63d0\u4f9b\u66f4\u591a\u7684\u4f8b\u5b50\uff0c\u8bf4\u660e\u88f8\u76d6\u83c7\u7d20\u53ef\u4ee5\u66f4\u5e7f\u6cdb\u5730\u7528\u4e8e\u6cbb\u7597\u5fc3\u7406\u5065\u5eb7\u95ee\u9898\u3002\u201d<\/p>\n
\u4e00\u6d41\u7684\u4f9b\u5e94\u5546<\/h2>\n
Creso\u975e\u6267\u884c\u4e3b\u5e2dAdam Blumenthal\u8868\u793a\uff0c\u6269\u5927\u8bd5\u9a8c\u8303\u56f4\u5c06\u6709\u52a9\u4e8eHalucenex\u6210\u4e3a\u201c\u4e00\u6d41\u7684\u4f9b\u5e94\u5546\u201d\u3002<\/p>\n
\u4ed6\u8bf4:\u201cHalucenex\u7684\u7ba1\u7406\u56e2\u961f\u7ee7\u7eed\u91c7\u53d6\u6b65\u9aa4\uff0c\u4ee5\u521b\u9020\u81f4\u5e7b\u5242\u548c\u7597\u6cd5\uff0c\u53ef\u7528\u4e8e\u9000\u4f0d\u519b\u4eba\u548c\u6025\u6551\u4eba\u5458\uff0c\u4ee5\u53ca\u65e5\u5e38\u4e2a\u4eba\u3002\u201d<\/p>\n
\u201c\u6269\u5927\u4e34\u5e8a\u8bd5\u9a8c\u53c2\u4e0e\u8005\u7684\u8303\u56f4\u662f\u4e00\u9879\u975e\u5e38\u6709\u524d\u666f\u7684\u53d1\u5c55\uff0c\u5c06\u4e3aHalucenex\u6210\u4e3a\u4e00\u6d41\u7684\u5927\u9ebb\u3001\u5927\u9ebb\u7d20\u548c\u81f4\u5e7b\u5242\u66ff\u4ee3\u836f\u7269\u4f9b\u5e94\u5546\u6253\u4e0b\u575a\u5b9e\u7684\u57fa\u7840\uff0c\u4ee5\u6ee1\u8db3\u65e5\u76ca\u589e\u957f\u7684\u6539\u5584\u5065\u5eb7\u7684\u6cbb\u7597\u9700\u6c42\u3002\u201d<\/p>\n
Halucenex\u9884\u8ba1\u5728\u6536\u5230\u52a0\u62ff\u5927\u536b\u751f\u90e8\u7684\u53d7\u7ba1\u5236\u836f\u7269\u548c\u7269\u8d28\u7ecf\u9500\u5546\u8bb8\u53ef\u8bc1\u4ee5\u53ca\u4e34\u5e8a\u8bd5\u9a8c\u6388\u6743\u540e\uff0c\u5c06\u5f00\u59cb\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c\u3002<\/p>\n
\u4e0e\u52a0\u62ff\u5927\u536b\u751f\u90e8\u7684\u8c08\u5224\u5df2\u8fdb\u5165\u540e\u671f\u9636\u6bb5\uff0c\u8be5\u516c\u53f8\u9884\u8ba1\u5c06\u5728\u4e0d\u4e45\u7684\u5c06\u6765\u83b7\u5f97\u8bb8\u53ef\u8bc1\u3002<\/p>\n
\u5fc3\u7406\u53cd\u5e94<\/h2>\n
PTSD\u662f\u5bf9\u5f3a\u70c8\u521b\u4f24\u4e8b\u4ef6\u7684\u5fc3\u7406\u53cd\u5e94\uff0c\u5305\u62ec\u90a3\u4e9b\u5a01\u80c1\u751f\u547d\u7684\u4e8b\u4ef6\u3002<\/p>\n
\u5bf9\u4e8e\u4e00\u540d\u9000\u4f0d\u519b\u4eba\u6765\u8bf4\uff0c\u8fd9\u79cd\u521b\u4f24\u53ef\u80fd\u4e0e\u76f4\u63a5\u6267\u884c\u6218\u6597\u4efb\u52a1\u3001\u5728\u5371\u9669\u7684\u6218\u533a\u6216\u5728\u56f0\u96be\u548c\u7d27\u5f20\u7684\u6761\u4ef6\u4e0b\u53c2\u52a0\u7ef4\u548c\u4efb\u52a1\u6709\u5173\u3002<\/p>\n
\u6839\u636e\u9000\u4f0d\u519b\u4eba\u4e8b\u52a1\u90e8(Department of Veterans ‘ Affairs)\u7684\u7edf\u8ba1\u6570\u636e\uff0c\u5927\u7ea610%\u7684\u666e\u901a\u6c11\u4f17\u6709\u53ef\u80fd\u5728\u751f\u547d\u4e2d\u7684\u67d0\u4e2a\u9636\u6bb5\u60a3\u4e0aPTSD\uff0c\u800c\u9000\u4f0d\u519b\u4eba\u7684\u8fd9\u4e00\u6bd4\u4f8b\u9ad8\u8fbe20%(\u53d6\u51b3\u4e8e\u4ed6\u4eec\u7684\u5de5\u4f5c\u6027\u8d28\u548c\u670d\u5f79\u5386\u53f2)\u3002<\/p>\n
\u5728\u73b0\u5f79\u519b\u4eba\u4e2d\uff0c\u7ea68%\u7684\u4eba\u5728\u67d0\u4e00\u5e74\u4e2d\u7ecf\u5386\u8fc7\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\uff0c\u800c\u666e\u901a\u4eba\u7fa4\u4e2d\u8fd9\u4e00\u6bd4\u4f8b\u4e3a5%\u3002<\/p>\n
Fleming\u8868\u793a\uff0c\u5c06\u8bd5\u9a8c\u8303\u56f4\u6269\u5927\u5230\u5305\u62ec\u9000\u4f0d\u519b\u4eba\u3001\u6025\u6551\u4eba\u5458\u548c\u975e\u9000\u4f0d\u519b\u4eba\uff0c\u5c06\u4e3a\u57fa\u4e8e\u81f4\u5e7b\u5242\u7684\u836f\u7269\u63d0\u4f9b\u8d8a\u6765\u8d8a\u591a\u7684\u8bc1\u636e\uff0c\u5e76\u6709\u52a9\u4e8eHalucenex\u5728\u5317\u7f8e\u548c\u5176\u4ed6\u5730\u533a\u63a8\u8fdb\u7814\u7a76\u548c\u8bb8\u53ef\u534f\u8bae\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002 \u8fd9\u9879\u8bd5\u9a8c\u6700\u521d\u662f\u4e3a\u4e86\u6d4b\u8bd5\u88f8\u76d6\u83c7\u7d20(\u795e\u5947\u8611\u83c7\u4e2d\u7684\u6709\u6548\u6210\u5206)\u5bf9\u9000\u4f0d\u519b\u4eba\u548c\u9996\u6279\u53cd\u5e94\u8005\u7684\u6cbb\u7597\u987d\u6297\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u7684\u7597\u6548\u3002 Creso\u516c\u53f8\u5c06\u975e\u9000\u4f0d\u519b\u4eba\u7eb3\u5165\u8c03\u67e5\u5bf9\u8c61\u4e4b\u524d\uff0cHalucenex\u6536\u5230\u4e86\u5927\u91cf\u6765\u81ea\u666e\u901a\u516c\u4f17\u7684\u54a8\u8be2\uff0c\u8fd9\u4e9b\u4eba\u4e5f\u60a3\u6709\u7cbe\u795e\u75be\u75c5\uff0c\u6b63\u5728\u5bfb\u6c42\u66ff\u4ee3\u7597\u6cd5\u3002 \u8be5\u516c\u53f8\u9884\u8ba1\uff0c\u975e\u9000\u4f0d\u519b\u4eba\u7684\u52a0\u5165\u5c06\u4f7f\u5176\u80fd\u591f\u6574\u7406\u989d\u5916\u7684\u6570\u636e\u96c6\uff0c\u4e3a\u88f8\u76d6\u83c7\u7d20\u4f5c\u4e3a\u66ff\u4ee3\u6cbb\u7597\u9014\u5f84\u65f6\u7684\u7597\u6548\u63d0\u4f9b\u771f\u5b9e\u7684\u4f8b\u5b50\u3002 \u8be5\u8bd5\u9a8c\u7684\u6570\u636e\u5c06\u7528\u4e8e\u63a8\u8fdb\u4e0e\u6f5c\u5728\u5408\u4f5c\u4f19\u4f34\u7684\u8ba8\u8bba\uff0c\u5305\u62ec\u836f\u7269\u5f00\u53d1\u5546\u3001\u5927\u578b\u5236\u836f\u516c\u53f8\u3001\u4fdd\u9669\u4f9b\u5e94\u5546\u548c\u76d1\u7ba1\u673a\u6784\uff0c\u4ee5\u8fdb\u4e00\u6b65\u5de9\u56faHalucenex\u4f5c\u4e3a\u65b0\u5174\u81f4\u5e7b\u5242\u836f\u7269\u9886\u57df\u7684\u5148\u884c\u8005\u7684\u5730\u4f4d\u3002 \u6ca1\u6709\u5f53\u8fc7\u5175\u7684\u597d\u5904 Halucenex\u9996\u5e2d\u6267\u884c\u5b98Bill Fleming\u8868\u793a\uff0c\u975e\u7ecf\u9a8c\u4e30\u5bcc\u7684\u53c2\u4e0e\u8005\u5c06\u4e3a\u8bd5\u9a8c\u5e26\u6765\u8bf8\u591a\u597d\u5904\u3002 \u4ed6\u8bf4:\u201c\u968f\u7740\u7f8e\u56fd\u7684\u5404\u79cd\u76d1\u7ba1\u53d8\u5316\u4ee5\u53caCOVID-19\u5bf9\u4eba\u7fa4\u5fc3\u7406\u5065\u5eb7\u72b6\u51b5\u7684\u5f71\u54cd\u4e0d\u65ad\u6076\u5316\uff0c\u8d8a\u6765\u8d8a\u660e\u663e\u7684\u662f\uff0c\u8ff7\u5e7b\u7597\u6cd5\u53ef\u80fd\u5728\u4e0d\u4e45\u7684\u5c06\u6765\u6210\u4e3a\u4e3b\u6d41\u3002\u201d \u201c\u8ba9\u6bcf\u5929\u7684\u4eba\u53c2\u4e0e\u6211\u4eec\u7684\u7814\u7a76\u548c\u5f00\u53d1\uff0c\u5c06\u4e3a\u6211\u4eec\u63d0\u4f9b\u66f4\u591a\u7684\u4f8b\u5b50\uff0c\u8bf4\u660e\u88f8\u76d6\u83c7\u7d20\u53ef\u4ee5\u66f4\u5e7f\u6cdb\u5730\u7528\u4e8e\u6cbb\u7597\u5fc3\u7406\u5065\u5eb7\u95ee\u9898\u3002\u201d \u4e00\u6d41\u7684\u4f9b\u5e94\u5546 Creso\u975e\u6267\u884c\u4e3b\u5e2dAdam Blumenthal\u8868\u793a\uff0c\u6269\u5927\u8bd5\u9a8c\u8303\u56f4\u5c06\u6709\u52a9\u4e8eHalucenex\u6210\u4e3a\u201c\u4e00\u6d41\u7684\u4f9b\u5e94\u5546\u201d\u3002 \u4ed6\u8bf4:\u201cHalucenex\u7684\u7ba1\u7406\u56e2\u961f\u7ee7\u7eed\u91c7\u53d6\u6b65\u9aa4\uff0c\u4ee5\u521b\u9020\u81f4\u5e7b\u5242\u548c\u7597\u6cd5\uff0c\u53ef\u7528\u4e8e\u9000\u4f0d\u519b\u4eba\u548c\u6025\u6551\u4eba\u5458\uff0c\u4ee5\u53ca\u65e5\u5e38\u4e2a\u4eba\u3002\u201d \u201c\u6269\u5927\u4e34\u5e8a\u8bd5\u9a8c\u53c2\u4e0e\u8005\u7684\u8303\u56f4\u662f\u4e00\u9879\u975e\u5e38\u6709\u524d\u666f\u7684\u53d1\u5c55\uff0c\u5c06\u4e3aHalucenex\u6210\u4e3a\u4e00\u6d41\u7684\u5927\u9ebb\u3001\u5927\u9ebb\u7d20\u548c\u81f4\u5e7b\u5242\u66ff\u4ee3\u836f\u7269\u4f9b\u5e94\u5546\u6253\u4e0b\u575a\u5b9e\u7684\u57fa\u7840\uff0c\u4ee5\u6ee1\u8db3\u65e5\u76ca\u589e\u957f\u7684\u6539\u5584\u5065\u5eb7\u7684\u6cbb\u7597\u9700\u6c42\u3002\u201d Halucenex\u9884\u8ba1\u5728\u6536\u5230\u52a0\u62ff\u5927\u536b\u751f\u90e8\u7684\u53d7\u7ba1\u5236\u836f\u7269\u548c\u7269\u8d28\u7ecf\u9500\u5546\u8bb8\u53ef\u8bc1\u4ee5\u53ca\u4e34\u5e8a\u8bd5\u9a8c\u6388\u6743\u540e\uff0c\u5c06\u5f00\u59cb\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c\u3002 \u4e0e\u52a0\u62ff\u5927\u536b\u751f\u90e8\u7684\u8c08\u5224\u5df2\u8fdb\u5165\u540e\u671f\u9636\u6bb5\uff0c\u8be5\u516c\u53f8\u9884\u8ba1\u5c06\u5728\u4e0d\u4e45\u7684\u5c06\u6765\u83b7\u5f97\u8bb8\u53ef\u8bc1\u3002 \u5fc3\u7406\u53cd\u5e94 PTSD\u662f\u5bf9\u5f3a\u70c8\u521b\u4f24\u4e8b\u4ef6\u7684\u5fc3\u7406\u53cd\u5e94\uff0c\u5305\u62ec\u90a3\u4e9b\u5a01\u80c1\u751f\u547d\u7684\u4e8b\u4ef6\u3002 \u5bf9\u4e8e\u4e00\u540d\u9000\u4f0d\u519b\u4eba\u6765\u8bf4\uff0c\u8fd9\u79cd\u521b\u4f24\u53ef\u80fd\u4e0e\u76f4\u63a5\u6267\u884c\u6218\u6597\u4efb\u52a1\u3001\u5728\u5371\u9669\u7684\u6218\u533a\u6216\u5728\u56f0\u96be\u548c\u7d27\u5f20\u7684\u6761\u4ef6\u4e0b\u53c2\u52a0\u7ef4\u548c\u4efb\u52a1\u6709\u5173\u3002 \u6839\u636e\u9000\u4f0d\u519b\u4eba\u4e8b\u52a1\u90e8(Department of Veterans ‘ Affairs)\u7684\u7edf\u8ba1\u6570\u636e\uff0c\u5927\u7ea610%\u7684\u666e\u901a\u6c11\u4f17\u6709\u53ef\u80fd\u5728\u751f\u547d\u4e2d\u7684\u67d0\u4e2a\u9636\u6bb5\u60a3\u4e0aPTSD\uff0c\u800c\u9000\u4f0d\u519b\u4eba\u7684\u8fd9\u4e00\u6bd4\u4f8b\u9ad8\u8fbe20%(\u53d6\u51b3\u4e8e\u4ed6\u4eec\u7684\u5de5\u4f5c\u6027\u8d28\u548c\u670d\u5f79\u5386\u53f2)\u3002 \u5728\u73b0\u5f79\u519b\u4eba\u4e2d\uff0c\u7ea68%\u7684\u4eba\u5728\u67d0\u4e00\u5e74\u4e2d\u7ecf\u5386\u8fc7\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\uff0c\u800c\u666e\u901a\u4eba\u7fa4\u4e2d\u8fd9\u4e00\u6bd4\u4f8b\u4e3a5%\u3002 Fleming\u8868\u793a\uff0c\u5c06\u8bd5\u9a8c\u8303\u56f4\u6269\u5927\u5230\u5305\u62ec\u9000\u4f0d\u519b\u4eba\u3001\u6025\u6551\u4eba\u5458\u548c\u975e\u9000\u4f0d\u519b\u4eba\uff0c\u5c06\u4e3a\u57fa\u4e8e\u81f4\u5e7b\u5242\u7684\u836f\u7269\u63d0\u4f9b\u8d8a\u6765\u8d8a\u591a\u7684\u8bc1\u636e\uff0c\u5e76\u6709\u52a9\u4e8eHalucenex\u5728\u5317\u7f8e\u548c\u5176\u4ed6\u5730\u533a\u63a8\u8fdb\u7814\u7a76\u548c\u8bb8\u53ef\u534f\u8bae\u3002<\/p>\n","protected":false},"author":4,"featured_media":12011,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[721],"yoast_head":"\n
Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005<\/title>\n<meta name=\"description\" content=\"Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005\" \/>\n<meta property=\"og:description\" content=\"Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-08T23:47:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:49:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Creso-Pharma-Halucenex-phase-II-psilocybin-trial-non-veteran-PTSD-sufferers-ASX-CPH.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005\" \/>\n<meta name=\"twitter:description\" content=\"Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/\",\"name\":\"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-06-08T23:47:15+00:00\",\"dateModified\":\"2023-08-29T17:49:48+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005","description":"Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005","og_description":"Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/","og_site_name":"smallcapsCN","article_published_time":"2021-06-08T23:47:15+00:00","article_modified_time":"2023-08-29T17:49:48+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Creso-Pharma-Halucenex-phase-II-psilocybin-trial-non-veteran-PTSD-sufferers-ASX-CPH.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_title":"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005","twitter_description":"Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/","url":"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/","name":"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-06-08T23:47:15+00:00","dateModified":"2023-08-29T17:49:48+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"Creso Pharma\u65e5\u524d\u5ba3\u5e03\uff0c\u5176\u52a0\u62ff\u5927\u6536\u8d2d\u5bf9\u8c61Halucenex Life Sciences\u5df2\u6269\u5927\u4e86\u8ff7\u5e7b\u836f\u88f8\u5934\u8349\u7d20(psilocybin) II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u62db\u52df\u8303\u56f4\uff0c\u5c06\u6cbb\u7597\u8010\u836f\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u975e\u9000\u4f0d\u60a3\u8005\u7eb3\u5165\u5176\u4e2d\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/creso-pharma-halucenex-phase-ii-psilocybin-trial-non-veteran-ptsd-sufferers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Creso Pharma\u7684Halucenex\u5c06\u88f8\u76d6\u83c7\u7d20\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6269\u5c55\u81f3\u975e\u8001\u5175\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\u60a3\u8005"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3259"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3259"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3259\/revisions"}],"predecessor-version":[{"id":12010,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3259\/revisions\/12010"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/12011"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3259"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}